How should a buyer evaluate vendors in the Animal Genetics Market beyond price per straw?

Reference population size and phenotype depth determine evaluation reliability more than list price. Ask for reliability percentages on the specific traits you select for, not aggregate index figures [22]. Read More

What contractual terms matter most when signing a genomic testing agreement?

Data ownership and portability clauses. Confirm you can export raw genotypes and retain rights to phenotype records if you switch providers, since European Data Act provisions now support that position [19]. Read More

How does the Animal Genetics Market treat intellectual property in breeding lines?

Protection relies on trade secrecy and terminal-cross structures rather than patents for conventional genetics. Gene-edited traits are patentable, which is shifting competitive strategy toward editing portfolios [9]. Read More

What integration problems arise when adding genomic data to existing herd software?

Identifier mismatches between laboratory sample codes and on-farm animal IDs cause most failures. Resolve tagging conventions before the first batch ships, or reconciliation costs exceed the testing spend [21]. Read More

Is embryo transfer worth the cost premium over artificial insemination for mid-sized herds?

Only where individual female genetic merit justifies multiplication — typically the top 5% of a herd. Below that threshold, conventional insemination with sexed semen delivers better return per dollar. Read More

How do investors assess risk in the Animal Genetics Market given commodity cycle exposure?

Recurring testing and service revenue proves more cycle-resistant than live animal sales. Companion animal diagnostics exposure further decouples earnings from agricultural commodity prices [14]. Read More

What regulatory nuance should exporters of genetic material watch most closely?

Destination-market rules on gene-edited progeny differ sharply from origin-market approvals. Product cleared in the United States may be blocked in the European Union, stranding inventory mid-chain [16]. Read More

Animal Genetics Market (2026 - 2035)

ID: MRFR/LS/5539-HCR 90 Pages Rahul Gotadki Last Updated: September 23, 2026

Animal Genetics Market Research Report: Size, Share, Trend Analysis By Products (Genetic Materials, Live Animals, and Others), By Services (Genetic Disease Tests, DNA Typing, and Gene Trait Tests), By End Userss (Veterinary Hospitals & Clinics and Diagnostic Centers), And By Region (North America, Europe, Asia-Pacific, And the Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

Animal Genetics Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)6.52%

2025 Market SizeUSD 6.54 Billion

2035 Market SizeUSD 12.04 Billion

Key Players

Genus plc (ABS

PIC)

Hendrix Genetics

EW Group (Aviagen

Hy-Line)

URUS Group (CRV

Trends

Collapsing Sequencing and Genotyping Costs
Protein Demand Growth in Emerging Economies
Government Artificial Insemination Programs

Opportunities

Sexed Semen Penetration in Emerging Dairy Systems
Aquaculture Genetics as an Underbuilt Category
Data Monetization Through Genomic Subscription Platforms

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Summary | |
1. 1.1 Study Assumptions & Market Definition | |
2. 1.2 Scope of the Study | |
3. 1.3 Research Methodology | |
2 Key Report Takeaways | |
1. 2.1 By Product Type (Value) | |
2. 2.2 By Testing Service Type (Value) | |
3. 2.3 By Technology (Value) | |
4. 2.4 By End User (Value) | |
5. 2.5 By Region | |
3 Market Size and Forecast (2021–2035) | |
1. 3.1 Historical Market Size (2021–2025) | |
2. 3.2 Current & Forecast Market Size (2026–2035) | |
3. 3.3 Year-over-Year Growth Analysis | |
4 Driver Impact Analysis | |
1. 4.1 Collapsing Sequencing and Genotyping Costs | |
2. 4.2 Protein Demand Growth in Emerging Economies | |
3. 4.3 Government Artificial Insemination Programs | |
4. 4.4 Disease Resistance Breeding Mandates | |
5. 4.5 Dairy and Swine Operation Consolidation | |
6. 4.6 Companion Animal Genomic Diagnostics | |
7. 4.7 Feed Conversion Efficiency Economics | |
5 Restraints Impact Analysis | |
1. 5.1 Gene-Editing Regulatory Uncertainty | |
2. 5.2 Smallholder Capital Constraints | |
3. 5.3 Genetic Diversity Erosion Concerns | |
4. 5.4 Cold Chain and Logistics Failure Rates | |
5. 5.5 Data Ownership Disputes Between Breeders and Platforms | |
6 Opportunities | |
1. 6.1 Sexed Semen Penetration in Emerging Dairy Systems | |
2. 6.2 Aquaculture Genetics as an Underbuilt Category | |
3. 6.3 Data Monetization Through Genomic Subscription Platforms | |
4. 6.4 Methane-Efficiency Trait Selection | |
5. 6.5 African Livestock Genetic Upgrading | |
7 Regional Market Share and Country-Level Analysis | |
1. 7.1 North America | | |
  1. 7.1.1 United States | |
2. 7.2 Europe | |
3. 7.3 Asia-Pacific | |
4. 7.4 South America | |
5. 7.5 Middle East & Africa | |
8 Future Outlook (2026–2035) | |
1. 8.1 Machine Learning in Genomic Prediction | |
2. 8.2 Gene Editing Moves From Trials to Herds | |
3. 8.3 Sustainability Reporting Pulls Genetics Into Scope | |
4. 8.4 Consolidation Reshapes the Supplier Base | |
9 Segmentation Analysis | |
1. 9.1 By Product Type (Value) | | |
  1. 9.1.1 Animal | | | |
    1. 9.1.1.1 Bovine | | | |
    2. 9.1.1.2 Porcine | | | |
    3. 9.1.1.3 Poultry | | | |
    4. 9.1.1.4 Canine | | | |
    5. 9.1.1.5 Equine | | | |
    6. 9.1.1.6 Aquaculture Species | | | |
    7. 9.1.1.7 Others | | |
  2. 9.1.2 Genetic Material | | | |
    1. 9.1.2.1 Semen | | | |
    2. 9.1.2.2 Embryo | | | |
    3. 9.1.2.3 DNA & Other Germplasm | |
2. 9.2 By Testing Service Type (Value) | | |
  1. 9.2.1 Genetic Disease Testing | | |
  2. 9.2.2 Genetic Trait & Performance Testing | | |
  3. 9.2.3 DNA Typing & Parentage Testing | | |
  4. 9.2.4 Other Specialised Tests | |
3. 9.3 By Technology (Value) | | |
  1. 9.3.1 Artificial Insemination (AI) | | |
  2. 9.3.2 Embryo Transfer (ET) | | |
  3. 9.3.3 Marker-Assisted & Genomic Selection | | |
  4. 9.3.4 CRISPR & Gene Editing | | |
  5. 9.3.5 Other Assisted-Reproduction Technologies | |
4. 9.4 By End User (Value) | | |
  1. 9.4.1 Breeding Companies & Associations | | |
  2. 9.4.2 Livestock Producers / Farms | | |
  3. 9.4.3 Veterinary Hospitals & Specialty Clinics | | |
  4. 9.4.4 Research & Academic Institutes | | |
  5. 9.4.5 Others | |
10 Competitive Landscape | |
1. 10.1 Market Share Analysis (2026) | |
2. 10.2 Competitive Benchmarking Matrix | |
3. 10.3 Company Profiles | |
11 Recent News & Developments | |
12 Report Scope and Methodology | |
13 Detailed Sources and Citations | |
14 Frequently Asked Questions | | LIST OF TABLES | |
TABLE 1 Global Animal Genetics Market Size & Forecast, by Revenue (USD Billion), 2021–2035 | |
TABLE 2 Global Animal Genetics Market – Year-over-Year Growth Analysis, 2021–2035 | |
TABLE 3 Driver Impact Analysis – Animal Genetics Market, 2026–2035 | |
TABLE 4 Restraint Impact Analysis – Animal Genetics Market, 2026–2035 | |
TABLE 5 Global Animal Genetics Market Size, by Region, 2021–2035 (USD Billion) | |
TABLE 6 North America Animal Genetics Market Size, by Country, 2021–2035 (USD Billion) | |
TABLE 7 Europe Animal Genetics Market Size, by Country, 2021–2035 (USD Billion) | |
TABLE 8 Asia-Pacific Animal Genetics Market Size, by Country, 2021–2035 (USD Billion) | |
TABLE 9 South America Animal Genetics Market Size, by Country, 2021–2035 (USD Billion) | |
TABLE 10 Middle East & Africa Animal Genetics Market Size, by Country, 2021–2035 (USD Billion) | |
TABLE 11 Global Animal Genetics Market Size, by Product Type (Value), 2021–2035 (USD Billion) | |
TABLE 12 Global Animal Genetics Market Size, by Testing Service Type (Value), 2021–2035 (USD Billion) | |
TABLE 13 Global Animal Genetics Market Size, by Technology (Value), 2021–2035 (USD Billion) | |
TABLE 14 Global Animal Genetics Market Size, by End User (Value), 2021–2035 (USD Billion) | |
TABLE 15 Competitive Benchmarking Matrix – Animal Genetics Market, 2026 | |
TABLE 16 Company Profiles – Key Players, Animal Genetics Market | |
TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 | |
TABLE 18 Report Scope & Methodology Summary | |
TABLE 19 Detailed Sources and Citations | |
TABLE 20 United States Animal Genetics Market Size, by Product Type (Value), 2021–2035 (USD Billion) | |
TABLE 21 United States Animal Genetics Market Size, by Technology (Value), 2021–2035 (USD Billion) | | LIST OF FIGURES | |
FIGURE 1 Animal Genetics Market Dynamics – Drivers, Restraints and Opportunities | |
FIGURE 2 Industry Value Chain Analysis – Animal Genetics Market | |
FIGURE 3 Porter's Five Forces Analysis – Animal Genetics Market | |
FIGURE 4 Global Animal Genetics Market Size Trend, 2021–2035 (USD Billion) | |
FIGURE 5 Market Share by Product Type (Value), 2025 vs 2035 | |
FIGURE 6 Market Share by Testing Service Type (Value), 2025 vs 2035 | |
FIGURE 7 Market Share by Technology (Value), 2025 vs 2035 | |
FIGURE 8 Market Share by End User (Value), 2025 vs 2035 | |
FIGURE 9 Regional Market Share Distribution, 2025 | |
FIGURE 10 Regional CAGR Comparison, 2026–2035 | |
FIGURE 11 Competitive Landscape – Estimated Revenue Share Positioning, 2026 | |
FIGURE 12 Company Strategic Positioning Matrix – Animal Genetics Market

Certified Researchers

Enquiry

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product Type (Value)	Live Animals; Genetic Material (incl. Animal: Bovine)	Live Animals – 58.4% share (2025)	Genetic Material – 7.20% CAGR
By Testing Service Type (Value)	Genetic Trait Tests; DNA Typing and Parentage Testing; Genetic Disease Testing	Genetic Trait Tests – USD 3.34 B (2025)	DNA Typing and Parentage Testing – 7.25% CAGR
By Technology (Value)	Artificial Insemination (AI); Embryo Transfer (ET); CRISPR and Gene Editing	Artificial Insemination (AI) – 52.9% share (2025)	CRISPR and Gene Editing – 7.88% CAGR
By End User (Value)	Breeding Companies & Associations; Livestock Producers/Farms; Veterinary Hospitals and Clinics	Breeding Companies & Associations – 35.6% share (2025)	Veterinary Hospitals and Clinics – 8.15% CAGR
By Region	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America – USD 2.43 B (2025)	Asia-Pacific – 7.94% CAGR

Market Segmentation Overview

By Product Type (Value)

Sub-Segment	Key Trend
Live Animals	Elite sire transactions above USD 50,000 supported by digital pedigree platforms and simplified quarantine routing
Genetic Material (incl. Animal: Bovine)	Embryo vitrification pushing post-thaw viability above 90%, enabling germplasm-only genetic upgrading

Live Animals leads this dimension because commercial buyers still price proven on-farm production records above any paper evaluation, and physical breeding stock carries that proof directly. Genetic Material grows faster on a cryopreservation and logistics argument: shipping a straw or embryo avoids the quarantine cost, mortality risk, and capital outlay of importing cattle. Bovine germplasm drives most of that volume, with dairy herds in Asia and Latin America the principal incremental buyers.

By Testing Service Type (Value)

Sub-Segment	Key Trend
Genetic Trait Tests	Cloud dashboards delivering per-cycle benchmarking on milk yield, carcass quality and feed conversion
DNA Typing and Parentage Testing	Handheld collection kits and sub-USD 30 per-sample genotyping expanding clinic and farm access
Genetic Disease Testing	Breed-specific hereditary panels covering 250-plus variants entering routine veterinary practice

Genetic Trait Tests hold the largest revenue pool because integrated poultry and swine operations can attach a hard dollar value to marginal feed efficiency gains replicated across millions of head. DNA Typing and Parentage Testing grows fastest as sequencing economics collapse, and laboratories bundle typing with trait panels to lift order value. Genetic Disease Testing follows companion animal demand, where hereditary screening has become a standard clinical expectation rather than a specialist referral.

By Technology (Value)

Sub-Segment	Key Trend
Artificial Insemination (AI)	Analytics-driven mating allocation and synchronized breeding protocols lifting conception rates
Embryo Transfer (ET)	Multiplication of top-decile female genetics in high-value dairy and beef operations
CRISPR and Gene Editing	United States regulatory clearance for edited swine establishing a commercial pathway

Artificial Insemination (AI) dominates on cost structure alone, delivering genetic gain at USD 50–200 per live calf where Embryo Transfer (ET) runs an order of magnitude higher and is therefore reserved for elite females worth multiplying. CRISPR and Gene Editing grows fastest from a small base, with disease resistance as the commercial wedge because producers already quantify PRRS and avian influenza losses. Divergent labelling regimes between the United States and European Union remain the principal brake on that trajectory.

By End User (Value)

Sub-Segment	Key Trend
Breeding Companies & Associations	Bundled scenario-modelling software raising client switching costs ahead of product purchase
Livestock Producers/Farms	Consolidated dairy and swine units procuring genetics directly with dedicated reproduction staff
Veterinary Hospitals and Clinics	Laboratory capacity expansion supporting same-week genomic diagnostic turnaround

Breeding Companies & Associations retain the largest revenue share through proprietary lines, R&D depth and distribution reach that smaller suppliers cannot match, with acquisitions steadily broadening species coverage. Veterinary Hospitals and Clinics expand fastest as diagnostic laboratories scale sample throughput into the tens of thousands monthly, making genomic testing a routine clinical step. Livestock Producers/Farms sit between the two, buying directly as herd consolidation justifies in-house genetic programs.

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”